【Takeda Pharmaceutical】Announces Dividend Increase | May 2026

Revision of Dividend Forecast and Policy Change

Takeda Pharmaceutical revised its dividend forecast released on May 9, 2025, raising the expected year-end dividend for the fiscal year ending March 2026 to 70 yen and projecting an annual dividend of 138 yen. This change is part of a dividend policy shift that emphasizes maintaining financial health while focusing on medium- to long-term corporate value enhancement and shareholder returns. The dividend policy has been revised to target a consolidated payout ratio of 50% or a DOE of 3.5%, aiming for stable profit redistribution.

Impact on Shareholders and Future Outlook

The increase in dividends aims to strengthen shareholder returns and enhance investment appeal. Takeda Pharmaceutical will continue to balance financial health with growth investments and shareholder returns over the medium to long term. Under the new dividend policy starting from March 2027, the company will promote stable dividend payments and aim to improve shareholder value.